Centessa Pharmaceuticals plc Ratios

Ratios Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin 2,981.37%-2,570.28%2,308.35%
EBIT Margin 2,916.90%-2,499.39%1,992.62%
EBITDA Margin 3,001.13%-2,161.02%2,309.58%
Operating Margin 2,916.90%-2,499.39%1,992.62%
Net Margin 2,971.10%-2,204.65%2,336.54%
FCF Margin 2,771.51%-2,342.20%1,408.22%
Efficiency
Assets Average 402.28M468.52M
Equity Average 286.21M318.89M
Invested Capital 336.17M236.24M510.49M
Asset Utilization Ratio 0.02-0.02
Leverage & Solvency
Interest Coverage Ratio -29.17-17.29-19.93
Debt to Equity 0.210.320.27
Debt Ratio 0.160.210.19
Equity Ratio 0.760.660.70
Times Interest Earned -29.17-17.29-19.93
Valuation
Enterprise Value 849.00M-100.40M520.58M1,732.68M
Market Capitalization 849.00M293.25M777.13M2,214.86M
Return Ratios
Return on Sales 29.71%-22.05%23.37%
Return on Capital Employed -0.47%-0.49%
Return on Invested Capital -0.51%
Return on Assets -0.38%-0.50%
Return on Equity -0.53%-0.74%